-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Atea Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
- Atea Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$69.8 M, a 67.9% decline year-over-year.
- Atea Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$192 M, a 47.9% decline year-over-year.
- Atea Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$164 M, a 25.7% decline from 2022.
- Atea Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$131 M, a 194% decline from 2021.
- Atea Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $138 M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)